Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Actikerall field-directed treatment study for actinic keratosis
2014-001171-31Phase 3Completed
- Sponsor
- Almirall
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in actinic keratosis (AK) comparing Actikerall with Vehicle control (2 arms). Primary endpoint: Complete clinical clearance at 8 weeks post last treatment. Started Jul 2014; status: completed.
02
Drugs
Actikerall
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on 2014-001171-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001171-31.